Skip to content

CEVA SANTE ANIMALE

Active
Public limited companyfounded 1978active for 47 yearsMetrologielaan 6, 1130 Brussel, BelgiumKBO/BCE: BE 0418.894.795

From the official registers: KBO 47 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

CEVA SANTE ANIMALE has been active since 1978 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €235,961 and a net result of €869,764. Equity is growing by about 5.2% per year across the filed financial years. Its solvency ranks better than 9% of 6,158 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
CEVA SANTE ANIMALEActiveChecked score 86/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 03-11-1978 Normal situation
Legal form
Public limited company
Registered office
Metrologielaan 6, 1130 Brussel
Activity
Wholesale of pharmaceutical and medical goods NACE 46460and 1 other
Establishment unit
2.015.604.174 1130 Brussel, since 13-12-1978
Financial year end
31 December
Peppol
Reachable since 01-01-0001
Company details

Who decides

Board
Auditor
BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES
Shareholders
Board & ownership

How it is doing

86 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Turnover
€30.8m
▲ 57.3%
Profit
€869,764
▲ 30.7%
Equity
€235,961
▼ 11.4%
Total assets
€13.6m
▲ 32.4%
Staff
28.2 FTE
▲ 15.1%
2025 accounts 5 days early
Filed on 26-07-2026at the National Bank
Financials
Why 86raises riskEquity €235,961 (1.7% of total assets)lowers riskFounded in 1978Profit of €869,764 (financial year 2025)Size: turnover €30.8m, 28.2 FTE, total assets €13.6mShow the evidence

Checked score

Score 2025
86 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 32% of its sector peers (NACE 46, small)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Weak
Solvency 27-1
equity 1.7% of total assets
Liquidity 17-7
short-term debt 98.3% · cash 13.3%
Profitability 63-2
return on assets 6.4%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (4,376 companies, NACE 46, small)
Last 24 months 11-2024: 0.4% 12-2024: 0.4%● unchanged vs 11-2024 01-2025: 0.4%● unchanged vs 12-2024 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.5%▲ +0.1 percentage points vs 06-2025highest value 08-2025: 0.2%▼ -0.3 percentage points vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026lowest value 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €20,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 1.0, compared with 1.0 in 2024, below 1; short-term debt: 98.3% and cash: 13.3% of total assets), and 98.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, small): better than 6% on solvency, 14% on liquidity, 50% on profitability and 57% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Equity €235,961 (1.7% of total assets)
NBB · annual accounts
lowers risk · Founded in 1978
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Profit of €869,764 (financial year 2025)
NBB · annual accounts
lowers risk · Size: turnover €30.8m, 28.2 FTE, total assets €13.6m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 9% of 6158 sector peers (2025).
NBB · sector comparison
Position among 6158 sector peers
Solvency
better than 9%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-07-2026, 5 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
5 days early
2024
22 days early
2023
22 days early
2022
31 days early
2021
29 days late
2020
2 days early
2019
18 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 10 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 10 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Key points

  • Caution: Among the weakest 9% on solvencysector median 45.2% · 6,158 companies 1.7% View
  • Positive: Turnover rose in 2025from €19.6m to €30.8m ▲ 57.3% View
  • Board changedlatest change 15-06-2026 · 2 in office 1 joined · 1 left View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

Documents

Annual accounts at the NBB

All 47 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about CEVA SANTE ANIMALE

What is the company number of CEVA SANTE ANIMALE?
0418.894.795. In Belgium the VAT number is the company number with BE in front: BE 0418.894.795.
Where is CEVA SANTE ANIMALE based?
The registered office is at Metrologielaan 6, 1130 Brussel.Company details
What does CEVA SANTE ANIMALE do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of CEVA SANTE ANIMALE?
Public limited company (NV).
When was CEVA SANTE ANIMALE founded?
On 03-11-1978.
Is CEVA SANTE ANIMALE still active?
Yes, CEVA SANTE ANIMALE is an active enterprise in the KBO register.
How many employees does CEVA SANTE ANIMALE have?
On average 28.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of CEVA SANTE ANIMALE?
€30.8m in financial year 2025, according to the filed annual accounts.
Is CEVA SANTE ANIMALE profitable?
In financial year 2025, CEVA SANTE ANIMALE made a profit of €869,764.
Where can I find the annual accounts of CEVA SANTE ANIMALE?
CEVA SANTE ANIMALE filed 47 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of CEVA SANTE ANIMALE due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to CEVA SANTE ANIMALE

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure